drospirenone has been researched along with Hot Flashes in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 8 (72.73) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Archer, DF; Gerlinger, C; Gude, K; Schaefers, M; Schmelter, T | 1 |
| Archer, DF; Gerlinger, C; Gude, K; Schaefers, M; Schmelter, T; Sutter, G | 1 |
| Shulman, LP | 1 |
| Cagnacci, A; D'Alterio, MN; Di Carlo, C; Melis, GB; Neri, M; Orrù, MM; Paoletti, AM | 1 |
| Chen, SR; Dong, XJ; Lin, JF; Lin, SQ; Qiao, J; Su, H; Sun, LZ; Wang, ML; Wang, SH; Wang, ZH; Xiong, ZA; Xu, YX; Yang, CS; Yang, X; Zhang, LJ; Zhang, YZ; Zhou, YZ; Zhu, J | 1 |
| Lin, JF; Lin, SQ; Qiao, J; Sun, LZ; Wang, ZH; Xiong, ZA; Xu, YX; Yang, X; Zhang, LJ; Zhou, YZ | 1 |
| Angsuwathana, S; Chaikittisilpa, S; Chaovisitsaree, S; Jaisamrarn, U; Jirapinyo, M; Kongmephol, W; Morakote, N; Panyakhamlerd, K; Suchartwatnachai, C; Taechakraichana, N; Techatraisak, K; Wilawan, K | 1 |
| Gerlinger, C; Gude, K; Hiemeyer, F; Schäfers, M; Schmelter, T | 1 |
| Benda, N; Holler, T; Schürmann, R | 1 |
| Ylikorkala, O | 1 |
| Choi, H; Kang, BM; Kim, JG; Lee, BS; Park, HM; Yoon, BK | 1 |
9 trial(s) available for drospirenone and Hot Flashes
| Article | Year |
|---|---|
A randomized, double-blind, placebo-controlled study of the lowest effective dose of drospirenone with 17β-estradiol for moderate to severe vasomotor symptoms in postmenopausal women.
Topics: Adult; Androstenes; Biopsy; Dose-Response Relationship, Drug; Double-Blind Method; Endometrium; Estradiol; Female; Hot Flashes; Humans; Hydrogen-Ion Concentration; Middle Aged; Placebos; Postmenopause; Vagina; Vaginal Smears | 2014 |
Population pharmacokinetic/pharmacodynamic evaluation of low-dose drospirenone with 17β-estradiol in postmenopausal women with moderate to severe vasomotor symptoms.
Topics: Adult; Androstenes; Body Mass Index; Double-Blind Method; Estradiol; Female; Hot Flashes; Humans; Middle Aged; Mineralocorticoid Receptor Antagonists; Placebos; Postmenopause; Smoking | 2014 |
Clinical effect of hormonal replacement therapy with estradiol associated with noretisterone or drospirenone. A prospective randomized placebo controlled study.
Topics: Adipose Tissue; Androstenes; Body Composition; Body Water; Body Weight; Double-Blind Method; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Hot Flashes; Humans; Insulin Resistance; Middle Aged; Mineralocorticoid Receptor Antagonists; Norethindrone; Postmenopause; Progesterone Congeners; Quality of Life; Treatment Outcome | 2015 |
Estradiol 1 mg and drospirenone 2 mg as hormone replacement therapy in postmenopausal Chinese women.
Topics: Aged; Androstenes; China; Double-Blind Method; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Middle Aged; Mineralocorticoid Receptor Antagonists; Placebos; Postmenopause; Vaginal Diseases | 2011 |
[Evaluation the efficacy and safety of estradiol and drospirenone tablets in the treatment of menopausal symptoms among postmenopausal Chinese healthy women:a randomized, multi-center, double-blind, placebo-controlled clinical study].
Topics: Aged; Androstenes; China; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Middle Aged; Mineralocorticoid Receptor Antagonists; Postmenopause; Tablets; Treatment Outcome; Vaginal Diseases | 2011 |
Clinical responses to the combination of estradiol and drospirenone in symptomatic postmenopausal Thai women.
Topics: Administration, Oral; Aged; Androstenes; Asian People; Drug Therapy, Combination; Estradiol; Estrogens; Female; Hormone Replacement Therapy; Hot Flashes; Humans; Middle Aged; Mineralocorticoid Receptor Antagonists; Postmenopause; Thailand; Time Factors; Treatment Outcome | 2011 |
An empirically validated responder definition for the reduction of moderate to severe hot flushes in postmenopausal women.
Topics: Androstenes; Diagnostic Self Evaluation; Double-Blind Method; Drug Therapy, Combination; Empirical Research; Estradiol; Estrogens; Female; Hot Flashes; Humans; Middle Aged; Mineralocorticoid Receptor Antagonists; Postmenopause; Prospective Studies; Severity of Illness Index; Treatment Outcome | 2012 |
Estradiol and drospirenone for climacteric symptoms in postmenopausal women: a double-blind, randomized, placebo-controlled study of the safety and efficacy of three dose regimens.
Topics: Aged; Androstenes; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Estradiol; Female; Hot Flashes; Humans; Middle Aged; Mineralocorticoid Receptor Antagonists; Postmenopause; Treatment Outcome | 2004 |
Efficacy and tolerability of estradiol 1 mg and drospirenone 2 mg in postmenopausal Korean women: a double-blind, randomized, placebo-controlled, multicenter study.
Topics: Aged; Androstenes; Climacteric; Double-Blind Method; Drug Therapy, Combination; Estradiol; Female; Hot Flashes; Humans; Korea; Menstruation; Middle Aged; Mineralocorticoid Receptor Antagonists; Postmenopause | 2007 |
2 other study(ies) available for drospirenone and Hot Flashes
| Article | Year |
|---|---|
Has the pendulum begun to swing back?
Topics: Androstenes; Estradiol; Female; Hot Flashes; Humans; Postmenopause | 2014 |
Drospirenone, a progestin with a unique cardiovascular profile, for safe contraception and treatment of menopausal symptoms.
Topics: Androstenes; Bone Remodeling; Contraceptives, Oral; Estradiol; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Menopause; Mineralocorticoid Receptor Antagonists; Osteoporosis; Premenstrual Syndrome; Progesterone Congeners | 2005 |